The Captia syphilis enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum, have been shown to offer several advantages over the current serological tests.' They are simple and rapid, and they give results that are read objectively.
The overall sensitivity of the Captia Syphilis-G, of To study the specificity of the Captia Syphilis-G and to assess the role of other diseases in producing false positive reactions, we examined 835 sera from non syphilitic patients, by the Captia Syphilis-G, according to the manufacturer's instructions (Mercia Diagnostics, UK). Sera (N = 728) giving negative TPHA and VDRL tests were obtained from specimens submitted to the Diagnostic Laboratory for routine testing. Of these 728 sera, three were positive for Captia Syphilis-G (specificity = 99-6%). On repeat testing, they remained negative for TPHA and VDRL tests and positive with Captia Syphilis-G. Sera (N = 107) from patients with diseases often associated with biologically false positive reactions were also examined by Captia Syphilis-G and Captia Syphilis-M. All the 107 specimens were negative by TPHA, VDRL and Captia Syphilis-M (table). All the rheumatoid factor positive sera were also negative on testing with the Captia Syphilis-G. In conclusion, the high overall specificity of the Captia Syphilis-G was confirmed in our study. However, the great number of falsepositive findings observed with sera from patients with Lyme borreliosis has to be emphasised. As 
